相关实验视频

Updated: Jul 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

肝细胞癌 - 东南亚更新

Satender Pal Singh¹, Vinod Arora, Tushar Madke

¹From the Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

Cancer journal (Sudbury, Mass.)

|October 5, 2023

概括

肝细胞癌 (HCC) 是全球主要的癌症,其病因从病毒转变为非病毒,特别是在高收入地区. 了解这些趋势是有效的预防和管理策略的关键.

科学领域:

肝病学和瘤学肝病学和瘤学
流行病学流行病学
公共卫生公共卫生

背景情况:

肝细胞癌 (HCC) 是一个重大的全球健康挑战,通常发生在具有遗传易感性和肝硬化等危险因素的个体中.
流行病学趋势揭示了HCC病因的地理和时间转变,从亚洲和非洲的主要病毒性病因转移到高社会人口统计指数地区的非病毒性病因.
人们已经认识到对HCC的遗传倾向,尽管在北美和欧洲以外的地区诊断的频率较低.

结论:

有效的HCC预防和管理需要量身定制的策略,考虑到区域流行病学变化和不断变化的风险因素.
监测和及时干预对于改善HCC风险患者的治疗结果至关重要.
对遗传倾向和非病毒性风险因素的进一步研究对于全球打击HCC的综合方法至关重要.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...